Pretreatment bowel manipulation during ultrasound-guided high-intensity focused ultrasound therapy for posterior wall uterine masses

• Published in: Taiwanese journal of obstetrics & gynecology Vol. 60; no. 6; pp. 1078 - 1083
• Main Authors: Wu, Meng-Hsing, Zhang, Yu, Chen, Dexin, Zhou, Ningbo, Li, Hui, Peng, Lingling, Huang, Min-Syuan, Kuo, Tsung-Cheng
• Format: Journal Article
• Language: English
• Published: China (Republic : 1949- ) Elsevier B.V 01.11.2021; Elsevier
• Subjects: Adenomyosis; Adenomyosis - pathology; Adenomyosis - therapy; Anal catheterization; Child; Extracorporeal Shockwave Therapy; Female; High-Intensity Focused Ultrasound Ablation - adverse effects; Humans; Leiomyoma - pathology; Leiomyoma - therapy; Myoma; Pain intensity; Pregnancy; Retrospective Studies; Treatment Outcome; Ultrasonography, Doppler, Color; Ultrasonography, Interventional - methods; Uterine Neoplasms - pathology; Uterine Neoplasms - therapy; Visual Analog Scale; Visual analog scale; Myoma; Adenomyosis; Pain intensity; Anal catheterization
• ISSN: 1028-4559; 1875-6263
• DOI: 10.1016/j.tjog.2021.09.020

High-intensity focused ultrasound (HIFU) therapy is a noninvasive alternative to conventional abdominal surgery in obstetrics and gynecology. The aim of this study is to evaluate the reduction of pain intensity with bowel manipulation before ultrasound-guided HIFU treatment in women with posterior wall uterine fibroids and/or adenomyosis. This is a multicenter retrospective observational study. Data from all patients who underwent HIFU therapy at three HIFU clinics (Sichuan Maternal and Child Health Hospital, Xiangya Hospital of Central South University, and Kuo General Hospital) between January 2019 and December 2019 were analyzed. We compared pain intensity with and without bowel manipulation during the HIFU treatment and evaluated tolerability without intravenous sedation. The presence of discomfort or pain during the HIFU procedure was evaluated using the visual analog scale (VAS). A total of 86 women were included in this study. All women underwent HIFU therapy with the PRO-2008 system in the supine position for posterior wall uterine fibroids and/or adenomyosis. Thirty-seven women received pretreatment anal catheterization with a condom and 49 women were not subjected to bowel manipulation. All patients received pretreatment condom-catheter device were well tolerated during the procedure of bowel manipulation. During the HIFU procedure, the women who had received bowel manipulation experienced lower pain intensity, especially less sacrococcygeal pain (VAS score 1.56 ± 1.46 vs 2.89 ± 1.61), target region pain (1.54 ± 1.30 vs 2.53 ± 1.29), and radiating pain (0.13 ± 0.34 vs 0.41 ± 0.54), compared with the women without bowel manipulation. Bowel manipulation with anal catheterization before HIFU therapy for posterior wall uterine masses can be safely performed and is effective as a low risk intervention to aid in reducing potential HIFU complications related to nerve involvement.